CIK: 0001744967 · Show all filings
Period: Q2 2020 (← Previous) (Next →)
Filing Date: Aug 14, 2020
Total Value ($000): $310,856 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Forma Therapeutics Holdings, Inc. | 1,578,388 | $73,379 | 23.6% | $46.49 | — | COM | 34633R104 |
| — | Springworks Therapeutics Inc | 557,356 | $23,409 | 7.5% | $21.68 | — | COM | 85205L107 |
| — | Odonate Therapeutics Inc | 496,505 | $21,022 | 6.8% | $14.81 | — | COM | 676079106 |
| — | Principia Biopharma Inc | 342,946 | $20,505 | 6.6% | $34.91 | — | COM | 74257L108 |
| — | Intercept Pharmaceuticals Inc | 403,688 | $19,341 | 6.2% | $88.27 | — | COM | 45845P108 |
| — | Allakos Inc | 243,868 | $17,524 | 5.6% | $51.45 | — | COM | 01671P100 |
| — | Iveric Bio, Inc. | 3,370,478 | $17,189 | 5.5% | $5.74 | — | COM | 46583P102 |
| — | Syros Pharmaceuticals Inc | 1,571,903 | $15,866 | 5.1% | $6.82 | — | COM | 87184Q107 |
| — | Sutro BioPharma Inc | 1,675,579 | $13,002 | 4.2% | $8.61 | — | COM | 869367102 |
| — | Atreca Inc | 510,296 | $10,859 | 3.5% | $18.84 | — | COM | 04965G109 |
| — | Aeglea BioTherapeutics, Inc. | 967,500 | $8,949 | 2.9% | $9.25 | — | COM | 00773J103 |
| GERN | Genron Corporation | 3,890,220 | $8,481 | 2.7% | $1.49 | 0.0% | COM | 374163103 |
| — | Aravive Inc | 576,066 | $6,705 | 2.2% | $5.87 | — | COM | 03890D108 |
| RYTM | Rhythm Pharmaceuticals Inc | 276,289 | $6,161 | 2.0% | $17.90 | +8.9% | COM | 76243J105 |
| FULC | Fulcrum Therapeutics, Inc. | 294,118 | $5,379 | 1.7% | $15.75 | 0.0% | COM | 359616109 |
| — | Portola Pharmaceuticals Inc | 318,429 | $5,279 | 1.7% | $11.84 | — | COM | 737010108 |
| — | Pieris Pharmaceuticals Inc | 1,620,249 | $5,203 | 1.7% | $2.86 | — | COM | 720795103 |
| — | Hookipa Pharma Inc | 400,245 | $4,651 | 1.5% | $6.73 | — | COM | 43906K100 |
| ACRS | Aclaris Therapeutics, Inc. | 2,608,117 | $4,225 | 1.4% | $1.36 | -1.6% | COM | 00461U105 |
| — | Aimmune Therapeutics, Inc. | 232,571 | $3,886 | 1.3% | $14.42 | — | COM | 00900T107 |
| — | Kala Pharmaceuticals Inc | 339,102 | $3,564 | 1.1% | $10.18 | — | COM | 483119103 |
| — | Bellus Health Inc | 333,631 | $3,450 | 1.1% | $7.55 | — | COM | 07987C204 |
| RCKT | Rocket Pharmaceuticals Inc | 138,197 | $2,892 | 0.9% | $19.67 | -8.4% | COM | 77313F106 |
| KALV | KalVista Pharmaceuticals Inc | 168,174 | $2,035 | 0.7% | $18.15 | -41.4% | COM | 483497103 |
| — | Catabasis Pharmaceuticals Inc | 300,000 | $1,929 | 0.6% | $4.37 | — | COM | 14875P206 |
| — | Soleno Therapeutics, Inc. | 750,000 | $1,665 | 0.5% | $2.22 | — | COM | 834203200 |
| UROV | Urovant Sciences Ltd | 157,480 | $1,550 | 0.5% | $6.59 | — | COM | G9381B108 |
| — | NGM Biopharmaceuticals, Inc. | 48,602 | $959 | 0.3% | $19.73 | — | COM | 62921N105 |
| — | Assembly Biosciences Inc. | 29,740 | $694 | 0.2% | $23.34 | — | COM | 045396108 |
| — | Akero Therapeutics, Inc. | 22,234 | $554 | 0.2% | $21.20 | — | COM | 00973Y108 |
| — | Amarin Corp PLC | 50,000 | $346 | 0.1% | $4.00 | — | SPONS ADR NEW | 023111206 |
| — | Verona Pharma PLC. | 43,456 | $203 | 0.1% | $4.67 | — | SPONSORED ADS | 925050106 |